A time of impunity for white-collar crime – Go Health Pro

A time of impunity for white-collar crime – Go Health Pro

Trevor Milton, founder of Nikola, leaves the courthouse during his fraud trial in New York, September 2022. BRITTAINY NEWMAN/AP The fraudster of the century, Bernard Madoff, ended his days in a federal prison in North Carolina, in April 2021, at the age of 82. His younger counterparts do not seem likely to meet this grim … Read more

China’s molecular ‘elevator’ boosts immunity 150-fold against cancer, viruses: scientists – Go Health Pro

China’s molecular ‘elevator’ boosts immunity 150-fold against cancer, viruses: scientists – Go Health Pro

China has unveiled its latest weapon in the battle against cancer – the world’s most powerful vaccine booster, capable of amplifying immune responses to tumours and infections up to 150-fold, according to researchers. The advance promises two potential benefits: enhanced treatments for malignancies such as melanoma and liver cancer and improved vaccine effectiveness against rapidly … Read more

Reciprocal Tariffs Actually Make Wealthy Americans Even Richer – Go Health Pro

Reciprocal Tariffs Actually Make Wealthy Americans Even Richer – Go Health Pro

Reciprocal tariffs will drive up the cost of most goods, making everyday life more expensive for American households. According to Fitch Ratings, the U.S. tariff rate on all imports has jumped from 2.5% in 2024 to around 22% today. Some research firms estimate the percentage is closer to 30%. As a result, more Americans may … Read more

Presidential Partisan Portfolios – A Wealth of Common Sense – Go Health Pro

Presidential Partisan Portfolios – A Wealth of Common Sense – Go Health Pro

A reader asks: There has been a clear distinction in recent years in sentiment data where party/political leaning sentiment goes in the opposite direction depending on who the President is. Anecdotally I have noticed in my friend group, family, social media, and even with some financial professionals online that people seem to be actually making … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Update on the DrugSorb-ATR Regulatory Process Management reiterated that their De Novo DrugSorb-ATR submission continued to be in interactive review with FDA, that their Medical Device License application to Health Canada was in advanced review, and that they continue to expect regulatory decisions in … Read more